Insmed Incorporated Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2025: -52.70%

Insmed Incorporated Return on Assets (ROA) is -52.70% for the Trailing 12 Months (TTM) ending March 31, 2025, a -7.34% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.
  • Insmed Incorporated Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2024 was -56.87%, a 35.83% change year over year.
  • Insmed Incorporated Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2023 was -41.87%, a 18.12% change year over year.
  • Insmed Incorporated Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2022 was -35.45%, a -10.80% change year over year.
  • Insmed Incorporated Return on Assets (ROA) for the Trailing 12 Months (TTM) ending March 31, 2021 was -39.74%, a 20.27% change year over year.
Key Data
Date Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share Dividend Per Share